文献速递流行病学与生物统计

女性生殖器切割/残割的疼痛性妇科和产科并发症:系统综述与荟萃分析

Painful gynecologic and obstetric complications of female genital mutilation/cutting: A systematic review and meta-analysis.
PubMed 文献 · PLoS Med · 2020-03-31

调整研究设计后,FGM/C与性交痛、会阴撕裂、排尿困难、会阴切开术和产程延长显著相关,与痛经、尿路感染、器械分娩和剖宫产关联证据不足。

要点

  • FGM/C女性性交痛、会阴撕裂、产程延长和会阴切开术风险约增两倍。
  • 排尿困难风险轻度增加,痛经、尿路感染、器械分娩和剖宫产关联不显著。
  • 临床医生需熟悉FGM/C健康后果,包括准确诊断、疼痛管理和产科计划。

核心结论

  • FGM/C女性中特定疼痛性结局显著更常见,性交痛、会阴撕裂、产程延长和会阴切开术风险约为非FGM/C女性的两倍。

研究设计与样本

  • 采用随机效应模型估计合并OR,并进行亚组分析评估研究设计差异,使用验证工具评估质量和偏倚风险,研究注册于PROSPERO(CRD42018115848)。

主要发现

  • 性交痛:6283例FGM/C与3382例非FGM/C参与者,合并OR 2.47(95%CI 1.45-4.21;I²=79%;P<0.01)。
  • 会阴撕裂:4898例FGM/C与4229例非FGM/C参与者,合并OR 2.63(95%CI 1.35-5.11;I²=67%;P=0.01)。
  • 排尿困难:3686例FGM/C与3482例非FGM/C参与者,合并OR 1.43(95%CI 1.17-1.75;I²=0%;P=0.01)。
  • 会阴切开术:29341例FGM/C与39260例非FGM/C参与者,合并OR 1.89(95%CI 1.26-2.82;I²=96%;P<0.01)。
  • 产程延长:7516例FGM/C与8060例非FGM/C参与者,合并OR 2.04(95%CI 1.27-3.28;I²=90%;P<0.01)。

关键数值与推荐

  • 痛经:7349例FGM/C与4411例非FGM/C参与者,合并OR 1.66(95%CI 0.97-2.84;I²=86%;P=0.06),证据不足以确定关联。
  • 尿路感染:4493例FGM/C与3776例非FGM/C参与者,合并OR 2.11(95%CI 0.80-5.54;I²=90%;P=0.10),证据不足以确定关联。
  • 器械分娩:5176例FGM/C与31923例非FGM/C参与者,合并OR 1.18(95%CI 0.78-1.79;I²=63%;P=0.40),证据不足以确定关联。
  • 剖宫产:34693例FGM/C与46013例非FGM/C参与者,合并OR 1.51(95%CI 0.99-2.30;I²=96%;P=0.05),证据不足以确定关联。

临床怎么用

  • 服务提供者必须熟悉FGM/C特有的健康后果,包括准确诊断、疼痛管理和产科计划。

局限性

  • 研究质量总体欠佳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The health complications experienced by women having undergone female genital mutilation/cutting (FGM/C) are a source of growing concern to healthcare workers globally as forced displacement and migration from countries with high rates of this practice increases. In this systematic review and meta-analysis, we investigate the association between FGM/C and painful gynecologic and obstetric complications in women affected by the practice. METHODS AND FINDINGS: We performed a comprehensive literature search from inception to December 19, 2019 of Ovid MEDLINE, Ovid EMBASE, The Cochrane Library (Wiley), and POPLINE (prior to its retirement) for studies mentioning FGM/C. Two reviewers independently screened studies reporting prevalences of painful gynecologic and obstetric sequelae resulting from FGM/C. Random effects models were used to estimate pooled odds ratios (ORs) for outcomes obtained from cross-sectional, cohort, and case-control designs. Subgroup analysis was performed to assess and control for effect differences introduced by study design. Validated appraisal tools were utilized to assess quality and risk of bias. Our study was registered with PROSPERO. Two reviewers independently screened 6,666 abstracts. Of 559 full-text studies assessed for eligibility, 116 met eligibility criteria, which included studies describing the incidence or prevalence of painful sequelae associated with FGM/C. Pooled analyses after adjustment for study design found that FGM/C was associated with dyspareunia (6,283 FGM/C and 3,382 non-FGM/C participants; pooled OR: 2.47; 95% confidence interval [CI]: 1.45-4.21; I2: 79%; p-value < 0.01), perineal tears (4,898 FGM/C and 4,229 non-FGM/C participants; pooled OR: 2.63; 95% CI: 1.35-5.11; I2: 67%; p-value = 0.01), dysuria (3,686 FGM/C and 3,482 non-FGM/C participants; pooled OR: 1.43; 95% CI: 1.17-1.75; I2: 0%; p-value = 0.01), episiotomy (29,341 FGM/C and 39,260 non-FGM/C participants; pooled OR: 1.89; 95% CI: 1.26-2.82; I2: 96%; p-value < 0.01), and prolonged labor (7,516 FGM/C and 8,060 non-FGM/C participants; pooled OR: 2.04; 95% CI: 1.27-3.28; I2: 90%; p-value < 0.01). There was insufficient evidence to conclude that there was an association between FGM/C and dysmenorrhea (7,349 FGM/C and 4,411 non-FGM/C participants; pooled OR: 1.66; 95% CI: 0.97-2.84; I2: 86%; p-value = 0.06), urinary tract infection (4,493 FGM/C and 3,776 non-FGM/C participants; pooled OR: 2.11; 95% CI: 0.80-5.54; I2: 90%; p-value = 0.10), instrumental delivery (5,176 FGM/C and 31,923 non-FGM/C participants; pooled OR: 1.18; 95% CI: 0.78-1.79; I2: 63%; p-value = 0.40), or cesarean delivery (34,693 FGM/C and 46,013 non-FGM/C participants; pooled OR: 1.51; 95% CI: 0.99-2.30; I2: 96%; p-value = 0.05). Studies generally met quality assurance criteria. Limitations of this study include the largely suboptimal quality of studies. CONCLUSIONS: In this study, we observed that specific painful outcomes are significantly more common in participants with FGM/C. Women who underwent FGM/C were around twice as likely as non-FGM/C women to experience dyspareunia, perineal tears, prolonged labor, and episiotomy. These data indicate that providers must familiarize themselves with the unique health consequences of FGM/C, including accurate diagnosis, pain management, and obstetric planning. REVIEW PROTOCOL REGISTRATION: The review protocol registration in PROSPERO is CRD42018115848.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Lurie JM, Weidman A, Huynh S, et al. Painful gynecologic and obstetric complications of female genital mutilation/cutting: A systematic review and meta-analysis. PLoS Med. 2020. PMID: 32231359. doi:10.1371/journal.pmed.1003088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。